Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials

BACKGROUND: The benefits and risks of anti-acid medication in patients with idiopathic pulmonary fibrosis (IPF) remain a topic of debate. We investigated whether use of anti-acid medication at baseline was associated with differences in the natural course of disease or influenced the treatment effec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Respir Res
Main Authors: Costabel, Ulrich, Behr, Jürgen, Crestani, Bruno, Stansen, Wibke, Schlenker-Herceg, Rozsa, Stowasser, Susanne, Raghu, Ganesh
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6122773/
https://ncbi.nlm.nih.gov/pubmed/30176872
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-018-0866-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados